# Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents

> **NCT00617695** · PHASE3 · COMPLETED · sponsor: **Impax Laboratories, LLC** · enrollment: 247 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Zolmitriptan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00617695
- **Lead sponsor:** Impax Laboratories, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 247 (ACTUAL)
- **Last updated:** 2024-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00617695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00617695, "Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00617695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*